Transoral robotic retropharyngeal node dissection

Givi, Babak; Troob, Scott H.; Stott, Will; Cordeiro, Teresa; Andersen, Peter E.; Gross, Neil D.

doi:10.1002/hed.24140

Cited by 25 publications

(19 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The robotic RPLND was conducted after completion of primary tumor removal via a technique that has previously been described . Selective neck dissection was performed of levels 2‐4 immediately after TORS resection.…”

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

“…Robotic retropharyngeal lymph node dissection (RPLND) is technically feasible via a transoral approach and has been described as both a staging tool and in the salvage setting. 9,10 In the present study, we describe a series of patients with oropharyngeal SCC who underwent transoral robotic RPLND. We hypothesized that adding RPLND does not add to the morbidity of the treatment in terms of surgical complications, length of hospitalization, and return of swallowing function.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Transoral robotic retropharyngeal node dissection in oropharyngeal squamous cell carcinoma: Patterns of metastasis and functional outcomes

et al. 2017

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Transoral robotic retropharyngeal node dissection in oropharyngeal squamous cell carcinoma: Patterns of metastasis and functional outcomes

et al. 2017

Self Cite

View full text Add to dashboard Cite

show abstract

“…Retropharyngeal nodal disease is difficult to access by surgical techniques and often requires radiotherapy treatment ( Figure 7B) (making these less ideal TORS candidates). 30 Extranodal extension ( Figure 7C) has been shown to have negative implications for recurrence-free survival. 31 Patients with no radiographically suspicious adenopathy and those with a single node under 3 cm would be good candidates for a TORS treatment approach.…”

Section: Nodal Disease In Torsmentioning

confidence: 99%

“…Other important considerations to note for the surgeon include any retropharyngeal nodal disease and extranodal extension. Retropharyngeal nodal disease is difficult to access by surgical techniques and often requires radiotherapy treatment (Figure B) (making these less ideal TORS candidates) . Extranodal extension (Figure C) has been shown to have negative implications for recurrence‐free survival …”

Section: Nodal Disease In Torsmentioning

confidence: 99%

Transoral robotic surgery for head and neck malignancies: Imaging features in presurgical workup

et al. 2019

View full text Add to dashboard Cite

The objective of this article was to review the indications for transoral robotic surgery (TORS) in head and neck malignancies. The role of imaging in patient selection will be specifically reviewed. TORS is a recently developed technique that allows minimally invasive surgeries to be performed in the head and neck. TORS has a role in the de‐escalation of oropharyngeal cancers, which allows for lower doses of chemoradiation therapy (this is a technique currently in clinical trials). Additionally, this technique allows for less invasive surgery and decreases associated complications. TORS can also be performed at other subsites. Cross‐sectional imaging has a prominent role to help identify suitable candidates for this type of surgery. This article will review important anatomy and staging related to TORS. Additionally, the key imaging features for patient selection (indications and contraindications) will be presented along with case illustrations.

show abstract

Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma with RPLN recurrence

et al. 2020

View full text Add to dashboard Cite

Background: Surgical access for retropharyngeal lymph node (RPLN) dissection is difficult. We aimed to examine the efficacy of transcervical endoscopic RPLN dissection (TSE-RPLND) for recurrent RPLN in nasopharyngeal carcinoma (NPC). Methods: From April 2013 to February 2019, a total of 31 patients with NPC diagnosed with RPLN recurrence underwent TSE-RPLND. The clinical characteristics, complications, and survival outcomes were retrospectively analyzed. Results: The mean duration of surgery, quantity of bleeding and postoperative hospitalization stay were 347.9 minutes, 107.7 mL, and 8.7 days, respectively. After a median follow-up of 31.0 months, the 2-year locoregional relapse-free survival, distant metastasis-free survival, progression-free survival, and overall survival rates were 63.9%, 95.2%, 59.9%, and 83.3%, respectively. The long-term incidences of swallowing problems, permanent nutrient tube, tongue atrophy, and shoulder problems were 6 (19.4%), 3 (9.7%), 3 (9.7%), and 3 (9.7%), respectively. Conclusions: TSE-RPLND is an effective method to treat RPLN recurrence in NPC, but nerve injury-related complications should not be ignored. You-Ping Liu, Shun-Lan Wang, Xiong Zou, and Rui You contributed equally to this study.

show abstract

Transoral robotic retropharyngeal node dissection

Abstract: TORS is feasible for accessing RPLNs. The procedure is well tolerated in patients with PTC; whereas patients with oropharyngeal SCC are at increased risk of complications. © 2015 Wiley Periodicals, Inc. Head Neck 38: E981-E986, 2016.

Cited by 25 publications

References 18 publications

Transoral robotic retropharyngeal node dissection in oropharyngeal squamous cell carcinoma: Patterns of metastasis and functional outcomes

Transoral robotic retropharyngeal node dissection in oropharyngeal squamous cell carcinoma: Patterns of metastasis and functional outcomes

Transoral robotic surgery for head and neck malignancies: Imaging features in presurgical workup

Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma with RPLN recurrence

Contact Info

Product

Resources

About